Article info
PDFTherapeutics
Randomised controlled trial
Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors
- Correspondence to Robert McKelvie
David Braley Cardiac, Vascular and Stroke Research Institute, McMaster University and Hamilton Health Sciences, Hamilton General Hospital Campus, 237 Barton Street E, Hamilton, Ontario L8L 2X2, Canada; robert.mckelvie{at}phri.ca
Citation
Compared with low-dose losartan, high-dose losartan decreases risk of death or hospital admission for heart failure in people with heart failure who are intolerant to ACE inhibitors
Publication history
- First published May 1, 2010.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions